Should I Hire a Fractional CRO If I Am Prepping for an Exit in 18 Months?

What exit-prep revenue leadership actually is and why it matters

A fractional CRO in a normal engagement is a growth hire. You bring them in because pipeline is thin, win rates are soft, or the sales team has outgrown a founder's ability to manage it, and you pay them to move a number upward. Prepping for an exit inverts that mandate almost entirely. The buyer is not paying you for the ARR you added last quarter; they are paying a multiple on the ARR they believe will still exist eighteen months after they own it. Everything that makes revenue *durable and legible* raises that multiple. Everything that makes revenue look improvised, concentrated, or personality-dependent shaves it.

That distinction matters because it changes who you should hire and what you should measure them on. A revenue leader whose entire track record is "took a company from $4M to $11M" may have built that growth on discounting, month-to-month contracts, and one heroic enterprise rep — all of which read as risk in a data room. A revenue leader who has sat on either side of an acquisition knows what a corporate development analyst opens first: the contract file, the cohort retention curve, and the forecast-versus-actuals history. Those three artifacts drive more valuation movement in an eighteen-month window than any new-logo push you could realistically run.

The company profile where this works is fairly specific. Roughly $5M–$15M ARR, a sales motion that functions but has never been documented, somewhere between 40 and 100 employees, and a board that has started using the word "process" in meetings. Below about $2M ARR, there is no engine to de-risk — you need founder-led selling and a full-time hire later. Above roughly $30M ARR you usually already have a full-time CRO and the question becomes whether to supplement them with diligence-specific help, which is a narrower and cheaper problem.

The word "fractional" is doing real work here. Exit prep is bounded, project-shaped work: audit, fix, document, hand off. It has a defined end state — a data room a buyer cannot poke holes in — and once you reach that state, the acquirer will almost certainly install their own revenue leader anyway. Paying a full-time CRO base plus equity plus a severance obligation for eighteen months of finite work is expensive in cash and messy on the cap table right when you least want cap table complexity. Two or three days a week from someone who has done this specific thing before is the better structure.

The trap is treating "fractional" as "cheap advisory." An advisor produces slides. An exit-prep engagement produces renegotiated contracts, a rebuilt CRM, a written playbook, and a forecast that has been accurate for three straight quarters. That requires someone willing to sit in deal reviews, call customers about renewal terms, and tell a top rep their comp plan is changing. If the candidate frames the role as coaching the CEO, the engagement will not survive contact with diligence.

There is also a defensive reason to hire outside the founding team. The people who built the current motion are the least able to see what is wrong with it. A commission plan that pays flat on one-year and three-year deals looks normal to the person who wrote it and looks like a valuation problem to anyone who has watched a buyer model retention. An outside operator with no ego investment in the existing system will name those things in week two rather than month nine, and in an eighteen-month window, seven months of politeness is most of your runway.

How the engagement runs, quarter by quarter

The sequencing matters more than the individual tactics, because several of these fixes take two or three quarters to show up in the data a buyer will look at. Forecast accuracy, in particular, cannot be manufactured in the final quarter — a buyer wants to see a run of quarters where the committed number and the actual number stayed close, which means you need the discipline installed by roughly month four to have four clean quarters on the board at signing.

Days 1–30: forensic audit. The fractional CRO reads every open opportunity, every contract renewing in the next twelve months, every rep's trailing performance, and product usage against contracted value. The output is a written revenue health assessment scored across a fixed set of dimensions: customer concentration, rep concentration, gross and net retention, expansion rate, forecast accuracy, pipeline coverage, sales cycle length, contract standardization, deal-size distribution, and comp alignment. Anything scored red becomes a workstream with an owner and a date. This document is also the honest baseline the board sees — the version before anyone has had time to clean it up.

Days 31–90: triage the dangerous items. Not everything, just the findings that would materially move a valuation or stall a deal. Short-notice cancellation rights in customer agreements. Renewals that exist only as a verbal understanding with a champion who has since changed jobs. A single rep holding an outsized share of closed revenue with no shadow relationship on those accounts. A standard contract template that legal has never actually blessed, so every deal became a bespoke negotiation. Each of these has a fix, and each fix takes weeks of unglamorous work rather than a decision.

Months 4–9: install the operating discipline. This is where forecast rigor gets built. Stage definitions get written down with entry and exit criteria, and the CRM gets configured so a rep cannot advance a deal without meeting them. Commit versus upside gets hard definitions — commit means the buyer has confirmed budget, an internal approval path, and a date; upside means a qualified evaluation without one of those. A weekly cadence replaces the monthly scramble. The point is not the meeting; it is that after two quarters, the number the CEO says out loud is the number that lands, and there is a paper trail proving it.

Months 10–15: build the data room and rehearse. Every diligence artifact gets drafted, reviewed, and stress-tested. Then you run a mock diligence session with a friendly outside party — a former corporate development professional, an M&A advisor, an investor who has bought companies — whose only job is to attack the materials. Gaps found here are cheap. Gaps found by the actual buyer are expensive, because they arrive as reasons to retrade the price.

Months 16–18 and the handoff. Materials go live, the CRO supports management presentations and diligence Q&A, and the final deliverable is a written transition plan: which reps to retain and why, how to reconcile two comp plans without triggering a wave of resignations, how CRM data migrates, how customers hear about the ownership change and from whom, and how to hold forecast accuracy steady through integration.

The loop back from the mock review is the part teams skip. Finding a problem in month thirteen and fixing it before the buyer arrives is worth far more than discovering it live, where every finding becomes leverage in a price negotiation rather than a maintenance item.

Costs, timelines, and what the money buys

Fractional CRO pricing generally runs in the mid-four to low-five figures per month depending on time commitment, company size, and the operator's background. A one-day-a-week advisory arrangement sits at the low end. A two-to-three-day-a-week operating engagement — which is what exit prep genuinely requires — sits meaningfully higher. Operators with actual transaction experience price above generalist revenue leaders, and reasonably so, because the value they add is knowing which findings a buyer will actually care about and which are noise. Get the specific number in writing along with the day commitment, because "fractional" without an hours definition is where engagements go wrong.

Compare that against the alternative. A full-time CRO at this company stage carries base plus variable plus meaningful equity, plus recruiting cost, plus a three-to-six-month ramp before they produce anything, plus a severance conversation when the acquirer brings their own leader. Against eighteen months of finite, well-defined work, the fractional structure is usually the cheaper and cleaner path — and it keeps the cap table simple, which matters more than founders expect once diligence starts.

On structure: pay a monthly base that covers the large majority of expected total compensation, and put a modest success component on top tied to *outcomes you can define in advance*. Good milestones are objective and verifiable — forecast accuracy held within a defined band across consecutive quarters, top-customer concentration reduced below a stated threshold, a defined share of the customer base converted to multi-year agreements, a data room that survives a mock diligence review without material findings. Pay the success component at close.

Resist the urge to solve compensation with equity. It requires a valuation exercise at exactly the moment you want a clean, boring cap table, it drags a new party into the waterfall, and it can complicate the closing mechanics for a percentage point of economics. A cash bonus at close achieves the same alignment without any of that.

Budget for the surrounding costs too, because the CRO's work generates them. Legal time to redraft the standard agreement and paper the renegotiated contracts is real. RevOps or analyst time to rebuild CRM hygiene and produce cohort analysis is real. If your billing data lives in spreadsheets, someone has to reconcile contracted value against actual usage and invoicing before anyone can defend the ARR number. These are not large line items individually, but they are the difference between a CRO who delivers documents and one who delivers documents backed by clean data.

On timeline: eighteen months is comfortable but not generous. Twelve months is workable if the company is already reasonably disciplined. Six months is triage — you can clean the CRM, standardize contracts going forward, and assemble the data room, but you cannot manufacture a forecast accuracy track record or meaningfully re-shape customer concentration. If you are inside six months, hire for data room production and diligence support specifically, and be honest with yourself that some of the valuation is already priced.

Where teams get this wrong

Hiring a growth CRO for a de-risking job. The most common failure. The company hires an impressive revenue leader who does exactly what impressive revenue leaders do: opens new segments, hires reps, expands pipeline. Eighteen months later the ARR is higher and the valuation is not, because the added revenue is early-cohort, unproven on retention, and sold by reps who have been there four months. Buyers discount immature revenue heavily. A dollar of five-year customer ARR on a three-year contract is not the same asset as a dollar closed last quarter, and pretending otherwise is the fastest way to spend eighteen months moving sideways.

Hiring new reps during the window. Related and equally costly. New reps ramp over months, consume management attention, and depress average productivity metrics precisely when a buyer is measuring productivity per rep. Unless you are backfilling a genuine hole, hold headcount flat and invest in making existing reps more effective. The exception is a deliberate shadowing hire on concentrated accounts — someone who builds a second relationship on your largest customers so the account is not one resignation away from being at risk.

Misreading which contract terms actually hurt. Payment timing is a common example, and it is easy to get backwards. Net-30 collects your cash in thirty days; net-60 makes you wait sixty. A buyer pushing you from net-30 out to net-60 is the concession that hurts — it stretches your working capital and shows up in the cash conversion a buyer models. Getting *shorter* payment terms is the win, not the risk. Similar clarity is needed on the terms that genuinely matter: short-notice termination rights, uncapped liability, most-favored-nation pricing clauses, unilateral renewal opt-outs, and any commitment to future functionality. Each of these is an assumed obligation the buyer inherits, and each one gets flagged.

Letting concentration go unaddressed until the end. Customer concentration and rep concentration both take quarters to fix, because the fix is either winning new accounts of meaningful size or deliberately spreading relationships across the team. If your top handful of customers represent an outsized share of ARR, that ratio only improves through sustained work. Discovering it in month fifteen leaves no runway.

Cleaning the CRM cosmetically. Deleting stale opportunities and closing dead deals makes a dashboard look better and fools nobody. Diligence teams pull raw exports and rebuild the funnel themselves. What actually matters is that stage definitions are consistent, close dates are honest, contract values in the CRM reconcile to what finance bills, and the historical record was not retroactively edited. A CRM that has clearly been groomed right before a sale reads worse than a messy one that is internally consistent.

Treating documentation as the last step. The revenue playbook — methodology, qualification criteria, the sales-to-customer-success handoff, comp structure, escalation path for non-standard deals — is not a document you produce in the final month. It is the thing that proves the motion is repeatable by people who are not the founders. Write it in month six, then live by it, so that when a buyer asks how deals get qualified, three different people describe the same process without checking notes.

Skipping the mock diligence entirely. Founders resist this because it feels like paying to be criticized. It is the highest-ROI few days in the entire engagement. Someone who has bought companies will find the soft spots in an afternoon, and each one they find is one the actual buyer will not get to use as leverage.

Assuming RevOps hygiene is somebody else's job. The CRO owns the revenue number; the RevOps function owns whether the number is provable. In exit prep those are the same job. If nobody owns data integrity between the CRM, the billing system, and the board deck, the three will disagree, and a buyer who finds three versions of ARR will assume the lowest is real.

Deciding whether this is your hire

Not every company prepping an exit needs a fractional CRO, and hiring one to solve the wrong problem wastes both the fee and the runway. Work the decision in order.

Start with whether you have a revenue engine at all. If you are under roughly $2M ARR with founder-led selling and no repeatable motion, there is nothing to de-risk — a buyer at that stage is acquiring the product and the team, not the go-to-market. Spend the money elsewhere.

If you do have a functioning motion, ask what the actual gap is. If the gap is that the numbers are messy — forecast unreliable, contracts inconsistent, no cohort analysis, ARR that finance and sales define differently — that is often a RevOps and finance problem before it is a leadership problem. A strong RevOps hire plus a diligence-experienced advisor may cost less and solve more than a fractional CRO. If the gap is that the motion works but nobody has ever written it down, ownership is diffuse, and hard conversations about comp and concentration keep getting deferred, that is precisely the fractional CRO job.

Then check the runway. Twelve months or more, and the full engagement makes sense. Under six months, scope it narrowly to data room production and diligence support.

Finally, screen for the right operator. The qualifying question is transaction experience — have they been through diligence, on either side? Ask them to walk through a specific engagement: what they found in the audit, what they fixed first, what the buyer flagged anyway, and what they would do differently. Ask for a reference from the acquirer's side, not just the seller's, because the acquirer's integration lead knows whether the revenue process actually held up after close. Someone who has only advised will describe frameworks. Someone who has operated will describe arguments they had about a comp plan.

One more consideration on the back end. If the exit proceeds on schedule, do not convert the fractional CRO to full-time — the acquirer will bring their own revenue leader, and you will have created a redundancy that becomes someone's severance problem. Keep them for thirty to sixty days post-close to execute the transition plan, then let the role end as designed. If the exit slips or gets called off, that is the moment to revisit a permanent hire, and by then you will have eighteen months of evidence about whether this person is the right one.

Related questions

What should a fractional CRO deliver before diligence starts?

A rolling revenue forecast by customer with stated assumptions, cohort retention analysis, per-rep productivity and quota attainment across recent quarters, a contract audit listing non-standard terms and their value at risk, and a win/loss review. Each should reconcile to finance's numbers without explanation.

Can the fractional CRO also serve as interim CEO?

No. The CRO's value is challenging the CEO's pipeline and forecast assumptions with no stake in defending them. Combining the roles removes the check that makes the arrangement useful, and buyers notice when one person owns both the number and the narrative about the number.

How much should new-logo growth matter in the final year?

Less than founders expect. Revenue closed in the last two quarters is immature and gets discounted on retention risk. Expansion within proven accounts and multi-year conversions of existing customers move valuation more reliably than the same dollars from brand-new logos.

Does hiring one signal weakness to buyers?

The opposite, generally. A documented revenue process with clear ownership reads as maturity. What signals weakness is a company where every answer in diligence routes back to the founder because nothing was ever written down or transferred.

What happens to the engagement after close?

Thirty to sixty days executing the transition plan, then it ends. The acquirer installs their own leader. A CRO who has built systems that outlast their departure makes the handoff clean, which protects any earn-out tied to post-close performance.

FAQ

How do I verify a candidate has real exit experience rather than adjacent exposure?

Ask for the specifics of one transaction: what the revenue health baseline looked like at the start, the first three things they fixed, what the buyer flagged despite the prep, and how the post-close transition went. Someone with genuine experience answers in concrete detail — a specific contract clause, a specific argument about a comp plan. Someone with adjacent exposure describes frameworks. Then ask for a reference on the buyer's side, because the integration lead knows whether the process held after close.

Should the fractional CRO report to the CEO or the board?

To the CEO operationally, with a standing quarterly slot in front of the board. Reporting to the board directly creates an authority conflict with the CEO that makes the day-to-day work harder. But the board needs unfiltered visibility into exit readiness, and the quarterly presentation of the revenue health assessment is the right mechanism — it also creates useful pressure to actually close out red items rather than carry them.

What if the existing VP of Sales sees this as a threat?

Address it directly in week one and be honest about the mandate. The fractional CRO is not there to take the VP's job; they are there for a bounded project that ends. Where it gets genuinely difficult is when the audit surfaces problems the VP created — a comp plan that rewarded the wrong behavior, a forecast culture built on optimism. Handle those as process findings rather than personal ones, but do not soften them, because the buyer will find the same things.

Is there a scenario where the answer is simply no?

Yes, several. Pre-product-market-fit companies have no engine to de-risk. Companies already carrying a competent full-time CRO usually need narrow diligence support instead of a second leader. And companies where the founders are unwilling to change anything — where the CRO's findings will be received and then ignored — should skip it, because the engagement will produce an accurate document that nobody acts on and eighteen months will pass anyway.

How does this differ from hiring an M&A advisor or investment banker?

Almost entirely. A banker runs the transaction: builds the buyer list, manages the process, negotiates terms. The fractional CRO changes the underlying asset the banker is selling — the contracts, the forecast reliability, the documented motion. They are complements, and the sequencing matters: the CRO's work should be largely finished before the banker takes the company to market, because you want the improved numbers in the materials rather than as promised future improvements.

What is the single highest-leverage thing to fix first?

Forecast accuracy, because it takes the longest and cannot be faked retroactively. A buyer looking at several consecutive quarters where the committed number landed close to actuals concludes the company understands its own business. That single pattern does more for credibility across the entire diligence process than any other artifact, and it is the one thing you cannot produce in the final quarter no matter how much effort you apply.

Sources

• https://hbr.org/2016/05/ma-the-one-thing-you-need-to-get-right
• https://www.mckinsey.com/capabilities/m-and-a/our-insights
• https://www.bain.com/insights/topics/m-and-a-report/
• https://corporatefinanceinstitute.com/resources/valuation/due-diligence-overview/
• https://www.investopedia.com/terms/d/duediligence.asp
• https://www.sec.gov/education/smallbusiness
• https://www.bvca.co.uk/Our-Industry/Private-Equity-Explained
• https://www.nvca.org/research/

Related on PULSE

• [What does a fractional CRO actually do day to day?](/knowledge)
• [How do I build a revenue operations playbook a buyer can use?](/knowledge)
• [What forecast accuracy do investors expect from a Series B SaaS company?](/knowledge)
• [How do I reduce customer concentration risk before a sale?](/knowledge)
• [Fractional vs full-time CRO: how to decide at $10M ARR](/knowledge)
• [What belongs in a revenue data room?](/knowledge)